Prolia and Fluoride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Prolia (denosumab) and Fluoride (fluoride). Common drug interactions include asthma among females and back disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Prolia and Fluoride. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Prolia?

Prolia has active ingredients of denosumab. It is often used in osteoporosis. eHealthMe is studying from 151,389 Prolia users. Check the latest studies of Prolia.

What is Fluoride?

Fluoride has active ingredients of fluoride. eHealthMe is studying from 2,301 Fluoride users. Check the latest studies of Fluoride.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

16 people who take Prolia and Fluoride together, and have interactions are studied.

Prolia and Fluoride drug interactions.

What are the common drug interactions of Prolia and Fluoride, by gender? *:

female:

  1. Asthma
  2. Burning sensation
  3. Dyspnoea (difficult or laboured respiration)
  4. Dyspnoea exertional (breathlessness or shortness of breath)
  5. Heart rate irregular
  6. Hypoaesthesia (reduced sense of touch or sensation)
  7. Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
  8. Infection
  9. Influenza
  10. Jaw disorder (jaw disease)

male:

  1. Back disorder
  2. Chills (felling of cold)
  3. Peripheral swelling
  4. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  5. Aortic aneurysm (enlargement of an aortic artery caused by a weakening of the artery wall)
  6. Capillary leak syndrome (capillary leaks plasma)
  7. Cardiac murmur (an heart sound in valve abnormality)
  8. Epistaxis (bleed from the nose)
  9. Fall
  10. Fatigue (feeling of tiredness)

What are the common drug interactions of Prolia and Fluoride, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Asthma
  2. Dyspnoea (difficult or laboured respiration)
  3. Dyspnoea exertional (breathlessness or shortness of breath)
  4. Heart rate irregular
  5. Infection
  6. Influenza
  7. Pneumonia
  8. Pyrexia (fever)
  9. Sinusitis (inflammation of sinus)
  10. Upper airway obstruction

50-59:

  1. Burning sensation
  2. Hypoaesthesia (reduced sense of touch or sensation)
  3. Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
  4. Mobility decreased (ability to move is reduced)
  5. Muscle spasms (muscle contraction)
  6. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  7. Neck pain
  8. Pain in jaw
  9. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  10. Abdominal pain

60+:

  1. Fall
  2. Jaw disorder (jaw disease)
  3. Delirium (wild excitement)
  4. Depressed level of consciousness
  5. Dizziness
  6. Drug ineffective
  7. Dysphagia (a condition in which swallowing is difficult or painful)
  8. Essential hypertension (primary hypertension)
  9. General physical health deterioration (weak health status)
  10. Hyperlipidaemia (presence of excess lipids in the blood)

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 4 people, 25.00%
  2. Humoral Immune Defect (impairment of humoral immunity): 4 people, 25.00%
  3. Cough: 3 people, 18.75%
  4. Asthma: 2 people, 12.50%
  5. Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 2 people, 12.50%
  6. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 12.50%
  7. Gait Disturbance: 2 people, 12.50%
  8. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 12.50%
  9. Vein Disorder: 1 person, 6.25%
  10. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Prolia and Fluoride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Prolia and Fluoride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Prolia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Fluoride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prolia and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fluoride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on denosumab and fluoride (the active ingredients of Prolia and Fluoride, respectively), and Prolia and Fluoride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: